Pseudohypoaldosteronism Type 2Symptoms, Doctors, Treatments, Advances & More
Learn About Pseudohypoaldosteronism Type 2
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Reading Hospital
Karthik Ranganna is an Internal Medicine specialist and a Nephrologist practicing medicine in West Reading, Pennsylvania. Dr. Ranganna is rated as an Advanced provider by MediFind in the treatment of Pseudohypoaldosteronism Type 2. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Chronic Kidney Disease, Liddle Syndrome, Pseudohypoaldosteronism Type 2, Kidney Transplant, and Nephrectomy. Dr. Ranganna is board certified in American Board Of Internal Medicine.
Bassett Medical Center
Eric Knight is a Nephrologist practicing medicine in Cooperstown, New York. Dr. Knight is rated as an Advanced provider by MediFind in the treatment of Pseudohypoaldosteronism Type 2. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses End-Stage Renal Disease (ESRD), Chronic Kidney Disease, Pseudohypoaldosteronism Type 2, and Liddle Syndrome.
Takayasu Mori practices practicing medicine in Tokyo, Japan. Mori is rated as an Elite expert by MediFind in the treatment of Pseudohypoaldosteronism Type 2. They are also highly rated in 24 other conditions, according to our data. Their clinical expertise encompasses Pseudohypoaldosteronism Type 1, Pseudohypoaldosteronism Type 2, Gitelman Syndrome, Nephrectomy, and Liver Embolization.
Summary: Pseudohypoaldosteronism is a pathology affecting children under 6 months of age, little known but which can have serious consequences. There are no real figures on the prevalence of this pathology in France. The exact pathophysiology is not known and the management is not currently codified. This is why it is interesting to study this pathology and its treatment on a national scale in order to thi...
Summary: The goal of this National Registry is to is to collect information from patients with rare kidney diseases, so that it that can be used for research. The purpose of this research is to: * Develop Clinical Guidelines for specific rare kidney diseases. These are written recommendations on how to diagnose and treat a medical condition. * Audit treatments and outcomes. An audit makes checks to see if ...